To: | ISHIHARA SANGYO KAISHA, LTD. (nixonptomail@nixonvan.com) |
Subject: | U.S. Trademark Application Serial No. 88251756 - ALFATROL - 1035-1386 |
Sent: | September 26, 2019 10:13:31 AM |
Sent As: | ecom120@uspto.gov |
Attachments: |
United States Patent and Trademark Office (USPTO)
Office Action (Official Letter) About Applicant’s Trademark Application
U.S. Application Serial No. 88251756
Mark: ALFATROL
|
|
Correspondence Address: |
|
Applicant: ISHIHARA SANGYO KAISHA, LTD.
|
|
Reference/Docket No. 1035-1386
Correspondence Email Address: |
|
EXAMINER’S AMENDMENT
Issue date: September 26, 2019
PARTIAL ABANDONMENT – APPLICATION HAS BEEN AMENDED
The above-referenced application is partially abandoned because applicant failed to file a response to the Office action dated February 28, 2019. See 15 U.S.C. §1062(b); 37 C.F.R. §2.65(a)-(a)(1); TMEP §718.02(a). To avoid partial abandonment, a response was due within six months from the date on which the USPTO sent the previous Office action; however, no response was received within this time period. See TMEP §711.
The outstanding Office action included a refusal that applied to only a portion of the application; therefore, only that portion of the application is abandoned. See 15 U.S.C. §1062(b); 37 C.F.R. §2.65(a)(1); TMEP §718.02(a).
The portion of the identification that was the subject of the refusal will be deleted from the application. The application will proceed with the following identification:
International Class 005: Veterinary preparations for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress; pharmaceutical preparations for skin care for animals; medicines for veterinary purposes for Companion animals, farm animals, dogs, cats, horses, chickens, cattle and pigs for the treatment of Anti-inflammatory, anti-shock, inflammation of digestive system, inflammation of respiratory system, anti-pancreatitis, pulmonary insufficiency, kidney disease, disseminated intravascular coagulation, chronic obstructive pulmonary disease, pyometra, spondylosis deformans, systemic inflammatory response syndrome, pneumonia, infectious peritonitis, sepsis, inhibiting thrombogenesis, allergy, tumor metastasis control, infectious disease, encephalitis and surgical stress
If applicant’s failure to respond was unintentional, applicant may file a petition to the Director to revive the portion of the application that abandoned. 37 C.F.R. §2.66(a); TMEP §§718.02(a), 1714.01(d). The petition must be filed within two months of the date of issuance of this letter and may be filed online via the Trademark Electronic Application System (TEAS) with a $100 fee. See 37 C.F.R. §§2.6(a)(15)(ii), 2.66(a)(1); TMEP §§718.02(a), 1714.01(a), (d). Once the petition is filed, please notify the Petitions Office at 571-272-8950 that a request to revive a partially-abandoned application was filed, indicating the application serial number.
Snabb, Sandra
/Sandra Snabb/
Examining Attorney
Law Office 120
571-272-4633
Sandra.Snabb@uspto.gov